Estimation of Population Survival Benefit for First Line Chemo- and Immuno Therapy

Breast CancerProportion of all cancer in Australia1 year survival benefit (Sensitivity range)5 year survival benefit (Sensitivity range)10 year survival benefit (Sensitivity range)
Stage I-II10.0%0.6% (0.6%-0.7%)4.8% (4.6%-5.0%)6.9% (6.7%- 7.2%)
Stage III1.6%3.0% (3.0%-3.1%)6.1% (5.8%-6.3%)0%
Stage IV0.5%5.3% (5.1%-5.5%)4.9% (4.7%-5.1%)0%
Whole Breast Cancer population12.1%1.0% (0.9%-1.2)4.4% (4.3%-4.6%)5.2% (5.0%-5.4%)